Neurodegeneration is dependent on activity, and vesicle depletion engages a transcriptional feedback loop that includes SREBP and tetraspanins.
INTRODUCTION
The structural stability of synaptic connections is central to maintaining brain function throughout adult life. As neural activity can be highly dynamic, this structural stability requires feedback mechanisms that can act across a range of timescales to maintain appropriate levels of synaptic proteins and lipids (Bezprozvanny and Hiesinger, 2013) . However, the molecular mechanisms that regulate synaptic components and vesicle pools over long timescales are incompletely understood. In addition, synapse loss is a common feature of many neurodegenerative diseases and can be both a critical component of disease onset and a strong predictor of cognitive impairment (Davies et al., 1987; DeKosky and Scheff, 1990; Terry et al., 1991; Masliah et al., 1991; Yoshiyama et al., 2007; Nemani et al., 2010) . Thus, identifying the molecular mechanisms by which adult neurons maintain synapses is essential to understanding both fundamental biological processes and disease states.
Photoreceptors are highly dynamic, with vesicle release rates that can vary across two orders of magnitude over short timescales. In cone photoreceptors, rapid synaptic vesicle recycling results in plasma membrane turnover equivalent to the entire surface area of the cell within an hour (Choi et al., 2005) . Similarly, photoreceptors in flies maintain extremely high rates of vesicle fusion, up to hundreds of vesicles per second per release site (de Ruyter van Steveninck and Laughlin, 1996) , requiring rapid replenishment (Stuart et al., 2007) . As photoreceptors must maintain their response properties across the lifespan of the animal, this highly dynamic character suggests specialized mechanisms for maintaining synaptic vesicle pools. Here, we used a forward genetic screen in Drosophila photoreceptors to uncover a mechanism for maintaining synaptic vesicles.
Studies in a variety of systems have implicated specific membrane phospholipids in the regulation of neuronal development and function. Phosphatidylethanolamine (PE) is highly enriched in synaptic vesicle membranes and is found at high levels in the mammalian retina (Anderson, 1970; Breckenridge et al., 1973) . One pathway for PE biosynthesis utilizes three enzymes: ethanolamine kinase (easily shocked in Drosophila), phosphatidylethanolamine cytidylyltransferase (pect), and ethanolamine phosphotransferase (CG33116 and CG7149). Intriguingly, knockdown of PE biosynthetic genes in Drosophila results in light-dependent retinal degeneration (Midorikawa et al., 2010) , and easily shocked (eas) mutants display neuronal hyper-excitability and defects in dendrite development that emerge after the dendritic field is established in sensory neurons (Pavlidis et al., 1994; Meltzer et al., 2017) . However, how mutations in PE biosynthetic enzymes would affect the levels of specific lipids in individual neuron types is unknown. In non-neuronal cells, PE negatively regulates SREBP, an evolutionarily conserved transcription factor, to control lipid biosynthesis Seegmiller et al., 2002) , and although many downstream targets of SREBP are known, SREBP targets in adult neurons are only incompletely understood (Shao and Espenshade, 2012) . Taken together, these data demonstrate that PE is required for the maintenance of neuronal structure and function and typically affects SREBP activity, but the mechanistic links between PE biosynthesis and neuronal structure, particularly at synapses, are unclear.
RESULTS

A Forward Genetic Screen Identifies Mutations in Pect
To identify genes required for photoreceptor function, we performed a forward genetic screen based on a visual behavioral assay using somatic mosaic animals that depends on functional synaptic connections between photoreceptors and their postsynaptic targets . From this screen, we obtained two recessive lethal mutations, omb362 and omb593, affecting conserved domains of the gene encoding Pect (omb362 D26N; omb593 H55Y; see STAR Methods). Further complementation testing identified an additional point mutation, designated 38K (A247V), as well as a molecular null allele, LL06325 (Schuldiner et al., 2008;  data not shown).
Pect Mutant Photoreceptors Undergo Progressive Degeneration and Lose Synaptic Markers
The Drosophila retina is composed of 800 facets, ommatidia, each of which contains eight photoreceptors (R cells), R1-R8. The six outer photoreceptors, R1-R6, extend axons into the lamina, the first optic neuropil, forming stereotyped columnar elements, cartridges, that contain six presynaptic axon terminals and their postsynaptic targets (Meinertzhagen and Hanson, 1993 ; Figure 1A ). Antibody markers label the Drosophila glycoprotein chaoptin, specific to R cell axon terminals (Fujita et al., 1982) , the vesicle-associated cysteine string protein (CSP) (Zin-smaier et al., 1994; Hamanaka and Meinertzhagen, 2010) , the SNARE complex member syntaxin (Schulze et al., 1995) , and the active zone marker Bruchpilot (Wagh et al., 2006; Hamanaka and Meinertzhagen, 2010) . On the day of eclosion (day 0), axon terminals in pect mutant R cells were morphologically similar to controls and displayed robust expression of CSP, syntaxin, and Bruchpilot ( Figures 1B-1D , 1F-1H, S1A-S1D, and S1H-S1J). Moreover, the morphology and arrangement of R cell bodies in the retina was also normal ( Figures 1E and 1I ). However, over the first 5 days of adult life, although control R cell axon terminals were unchanged, mutant axon terminals developed irregular, swollen morphologies and progressively lost both CSP and syntaxin labeling but retained Bruchpilot labeling ( Figures 1N-1P , 1R-1T, and S1A-S1S). In parallel, the retina degenerated, consistent with previous observations (Figures 1Q and 1U; Midorikawa et al., 2010) . To verify that these phenotypes were caused by mutations in pect, we expressed a UAS-pect rescue construct in mutant animals under the control of the photoreceptor-specific driver GMR-Gal4. In control flies, expression UAS-pect had no effect on R cell axon terminals, and in somatic mosaic mutants, expression of this construct had no effect at eclosion but strongly rescued all R cell phenotypes 5 days later ( Figures 1J-1M , 1V-1Y, S1A, and S1T-S1Y; data not shown). Somatic mosaic animals in which R cells were homozygous mutant for any of the four pect alleles, including the putative molecular null allele LL06325, displayed indistinguishable phenotypes and were rescued UAS-pect (Figures S1N-S1Y; data not shown). Finally, pect mutant photoreceptors were morphologically normal during mid-pupal development (data not shown). Thus, strong reduction of function alleles of pect causes degeneration and loss of synaptic marker labeling in mature photoreceptors.
To examine the specificity of the synaptic changes seen in pect mutants, we used five additional markers associated with synaptic terminals in Drosophila (S€ udhof et al., 1989; Lahey et al., 1994; Klagges et al., 1996; Harden et al., 1996; Godenschwege et al., 2004; Hofbauer et al., 2009; Hamanaka and Meinertzhagen, 2010) . Aa2/2 labels the epidermal growth factor receptor pathway substrate clone 15 (EPS-15), which localizes to the synaptic vesicle pool surrounding the heads of capitate projections. Anti-p21-activated kinase (DPAK) recognizes Drosophila p21-activated kinase, and anti-synapsin recognizes several synapsin isoforms. Discs large (DLG) labels both pre-and postsynaptic structures and capitate projections. Of these, expression of A2/2, DLG, and synapsin are reduced in pect mutant R cell axon terminals 5 days after eclosion, although expression of dynamin and DPAK were unaffected ( Figure S1A ). Thus, some, but not all, synaptic markers are affected by this manipulation.
We next examined eye-specific somatic mosaic animals using electron microscopy (Figures 2 and S2) . In pect mutants observed within 8 h of eclosion, cartridge organization was typically normal (Figures 2A and 2B) with only a modest increase in the variance in the number of R1-R6 terminals observed in mutant cartridge cross sections relative to controls ( Figure 2P ). Within each cartridge, the number of presynaptic release sites at T-bar ribbons between R cells and their postsynaptic targets was the same in pect mutant terminals as in controls ( Figure 2Q ). These observations argue strongly that R cells in pect mutant animals make synapses only with the correct postsynaptic targets. However, although individual R cell axon terminals were of normal size (Figures 2A-2D and 2R), synaptic vesicles were reduced in number, lowering the density of synaptic vesicles to approximately 55% of that in controls ( Figures 2C, 2D , 2J, and 2S). These remaining vesicles were evenly spaced and distributed in small patches ( Figure 2I ), a phenotype previously observed in endocytic mutants Verstreken et al., 2003; Dickman et al., 2005) . To quantify this ''patchy'' distribution, we compared R a , the measured nearestneighbor distance between synaptic vesicle profiles, to R e , the same distance based on the calculated density of synaptic vesicles assuming a random distribution ( Figure S2A ). If vesicles were distributed at random, this ratio would be 1 but, consistent with the presence of vesicle clusters, was significantly less than 1 in pect mutant terminals ( Figure S2B ). A further phenotype, also found in other endocytic mutant R cell terminals, was an approximately 70% increase in the number of shallow profiles of capitate projection organelles, sites of vesicle endocytosis ( Figure S2C ; Fabian-Fine et al., 2003) . Finally, pect mutant terminals also contained rare profiles of dense-core vesicles at eclosion ( Figures 2H and S2D ), in addition to the small, clear synaptic vesicles, which contain histamine (Borycz et al., 2005) , suggesting that pect mutant terminals may accumulate neuropeptides. In sum, 8 h after eclosion, pect mutant terminals have normal synapses but display defects consistent with changes in vesicle membrane trafficking and endocytosis.
Ultrastructural analysis of pect mutants revealed additional neurodegenerative changes in older flies. At 5 days of age, R1-R6 terminals in control flies appeared relatively unchanged from eclosion (data not shown). However, many pect mutant R1-R6 terminals lacked most vesicles and displayed electrondense cytoplasm, consistent with degeneration ( Figure 2G ; Brandst€ atter et al., 1991) . This degeneration was progressive, with most terminals being normal soon after eclosion, transitioning smoothly to most terminals displaying severe degeneration at 5 days of age ( Figure S2E ). Associated with these changes, there was also a general loss of capitate projections and synaptic T-bar ribbons, as well as the presence of structures with the morphological character of endoplasmic reticulum (Figures 2K and S2F; data not shown). Finally, although pect mutant photo-receptor cell bodies appeared normal 8 h after eclosion, the retinas of 5-day-old animals also underwent degeneration, displaying both electron-dense cytoplasm and loss of rhabdomere structure ( Figures 2L-2O ). Thus, Pect is required to maintain the structural organization of R cell bodies and axon terminals.
Pect Is Required for the Biosynthesis of Specific Phospholipid Species We next examined how mutations in pect altered phospholipid biosynthesis by performing mass spectrometric (MS) analysis of retinas dissected from control and pect mutant somatic mosaic flies on the day of eclosion. As phosphatidylcholine (PC) and phosphatidylethanolamine (PE) are the most common constituents of membranes in Drosophila (Jones et al., 1992) , we compared the relative levels of PE and PC molecular species containing between 16 and 24 carbons in fatty acid chain length. In addition to being classified by their headgroups (PE or PC in this case), phospholipid structures are described by the lengths of the carbon chains and by the number of carbon-carbon double bonds within these chains, summed over both fatty acid groups. By convention, phospholipids with 36 or more carbons and 6 or more double bonds are classified as long chain, polyunsaturated fatty acids (LC-PUFAs). These studies revealed that, in control retinas, 76% of membrane glycerophospholipids comprised PC species, and PE species accounted for the remaining 24% (Table S1 ). Moreover, photoreceptor membranes include a diverse repertoire of PC and PE species, with 97.9% of lipid species containing fewer than 6 double bonds and 36 or fewer carbons and 2.1% comprising LC-PUFA species with between 6 and 12 double bonds ( Figure 3A ). In pect mutant retinas, the overall proportions of PC and PE species were not significantly changed (81% PC species and 19% PE species). However, loss of Pect activity caused a significant shift in the relative levels of a specific subset of PC and PE species ( Figure 3B ). Among PC species, loss of Pect activity lowered the levels of PC 32:0 while increasing the levels of PC 32:2 ( Figure 3B ; Table S1 ). All of these changes were substantially reversed by expression of a rescuing Pect transgene. Among PE species, loss of Pect activity significantly lowered the levels of PE 34:1 and PE 36:2, changes that were also significantly reversed by the rescuing Pect transgene. Finally, aggregate levels of PC and PE LC-PUFA species were not affected by Pect manipulation. These data argue that Pect is not essential for the synthesis of either PC or PE per se but that Pect activity is required to maintain the appropriate levels of specific phospholipid species, with particular effects on the relative proportions of specific PC and PE species. Thus, the degenerative phenotypes we observed in pect mutant retinas are not the result of generalized deficits in membrane phospholipid composition but rather reflect changes in the biosynthesis of a small number of specific phospholipids.
Pect Is Expressed in R Cells
To examine Pect expression, we used an antibody against Pcyt2, the human homolog of Pect, which shares 59% identity with Drosophila Pect. In control flies, on the day of eclosion, this antibody specifically labeled R1-R6 axon terminals ( Figures  S3A-S3C ), a staining pattern that disappeared when R cells were homozygous mutant for the molecular null allele of pect, 
Axon Terminal Degeneration in Pect Mutant R Cells Is Activity Dependent
Deficits in PE biosynthesis cause light-dependent degeneration of R cell rhabdomeres (Midorikawa et al., 2010) . To determine whether the axonal phenotypes in pect mutant R cells were activity dependent, pect somatic mosaic animals were reared in the dark to reduce R cell activity (Niven et al., 2007) . Under these conditions, pect mutant axon terminals were more strongly labeled by chaoptin, and nearly normal in morphology, compared with pect mutants reared under standard lighting ( Figures 4A, 4C , 4D, 4F, 4G, 4I, and 4N). However, in spite of strong suppression of the degeneration of the axon terminal, synaptic marker expression was not increased by dark rearing (Figures 4B, 4E , 4H, and 4M). We next examined whether this suppression was directly due to reductions in light exposure via effects on phototransduction or reflected changes in light-evoked synaptic activity. To do this, we took advantage of a null allele in synaptotagmin 1 (syt) that blocks activity-dependent vesicle release at the neuromuscular junction and in R cells (DiAntonio et al., 1993; Stowers and Schwarz, 1999) . Importantly, syt homozygous mutant R cells displayed no detectable changes in axon terminal morphology or synaptic staining (Stowers and Schwarz, 1999 ; data not shown). Strikingly, as in dark-reared flies, pect, syt double mutant R cells displayed significantly reduced degeneration of axon terminals but continued to display the characteristic loss of synaptic markers associated with pect mutations ( Figures 4J-4N ). Finally, both dark rearing of pect mutants and pect, syt double mutants displayed suppression of cell body degeneration in the retina ( Figures S4A-S4D ). Taken together, these data demonstrate that degeneration of the R cell axon terminal and cell body is activity dependent and requires synaptic vesicle exocytosis. These studies also show that the loss of synaptic protein expression seen in pect mutants was unaffected by reductions in activity, suggesting a distinct underlying mechanism.
Loss of Synaptic Marker Expression in Pect Mutant R Cells Requires SREBP
In non-neuronal cells, reductions in PE levels activate the transcription factor SREBP, inducing expression of metabolic , pect omb593 somatic mosaic animals (light blue), and pect omb593 somatic mosaic animals expressing eye-specific, full-length Pect (dark blue), displaying the relative percent contribution of each species. Left graphs display a subset of PC species as well as an aggregate sum of all PC species with six or more double bonds; right graphs display the same subsets of PE species as well as an aggregate sum of all PE species with six or more double bonds. Data represented as mean ± SEM. Differences are significant at **p < 0.01 and *****p < 0.0001 (one-way ANOVA; t test). n = 4 replicates of 20 retinas per genotype. See also Figure S3 and Table S1. regulatory factors, including genes involved in lipid synthesis. As pect mutants disrupt the synthesis of specific PE species, we hypothesized that increased activation of SREBP might be functionally relevant. To test this, we first expressed an RNAi construct directed against SREBP in pect somatic mosaic mutants. Western blotting of dissected retinas revealed that this construct reduced SREBP expression by approximately 83% ( Figure S5A ). Control flies expressing either GMR-Gal4 alone or GMR-Gal4 driving SREBP-IR displayed normal synaptic vesicle staining and stereotyped cartridge structures ( Figures 5A-5C ; data not shown). Strikingly, pect mutants expressing SREBP-IR displayed increased expression of CSP relative to pect mutants alone (Figures 5D-5I and 5Q). However, knockdown of SREBP failed to suppress degeneration of the axon terminal or the retina ( Figure 5P ; data not shown). Next, we confirmed these RNAi studies by reducing the activity of SREBP by 50% using animals that were heterozygous for a molecular null allele, SREBPD189. Indeed, reducing SREBP dosage produced suppressed the loss of CSP expression (Figures 5Q and S5B-S5J). Thus, SREBP is required for the loss of CSP expression seen in pect mutant R cells, a process that is mechanistically distinct from degeneration of the axon terminal.
We next tested whether this epistatic genetic interaction between pect and SREBP was specific to Pect or more general to PE biosynthesis. The CDP-ethanolamine pathway that includes Pect converts ethanolamine to PE in three steps (Figure S5K ). If the CDP-ethanolamine pathway was specifically required in adult R cells, inhibiting either the first or last enzymatic step should produce a degenerative phenotype similar to that in pect mutants. However, three genes have been identified as ethanolamine phosphotransferases, making genetic dissection of the third enzymatic step complex. We therefore used eye-specific expression of an RNAi construct directed against eas, the upstream gene, and successfully phenocopied the degenerative phenotype, producing bloated R cell axon terminals and a decrease in CSP staining (Figures 5P, 5Q , and S5L-S5Q). Moreover, knockdown of SREBP in the background of reduced Eas modestly suppressed the loss of CSP staining (Figures 5P, 5Q , and S5R-S5T). Thus, the degenerative phenotypes we observed in pect mutants, and the genetic epistasis with SREBP, reflects deficits in this biosynthesis pathway. (M) Relative CSP labeling intensity in dark-reared control, dark-reared pect omb593 , and pect omb593 , syt double mutants compared to pect omb593 mutants. (N) Cartridge quantification using chaoptin labeling for pect omb593 mutants, dark-reared control, dark-reared pect omb593 , pect omb593 , and pect omb593 , syt double mutants. Scale bar, 15 mm. Data are represented as mean ± SEM. Differences are significant at ***p < 0.001 (one-way ANOVA; t test). n = 9 for each genotype. See also Figure S4 . (P) Relative CSP labeling intensity in pect omb593 mutants expressing UAS-SREBP-IR and UAS-SREBP-NTDel relative to pect omb593 mutants expressing GMR-Gal4 alone, pect omb593 mutants containing SREBPD189/+ compared to pect omb593 mutants alone, pect omb593 mutants expressing SIP-IR using GMR-Gal4 relative to pect omb593 mutants expressing GMR-Gal4 alone, and eye-specific eas-IR with SREBP-IR relative to flies expressing eas-IR alone. (Q) Cartridge quantification using chaoptin labeling for pect omb593 mutants expressing pect omb593 mutants expressing UAS-SREBP-IR and UAS-SREBP-NTDel relative to pect omb593 mutants expressing GMR-Gal4 alone, pect omb593 mutants containing SREBPD189/+ compared to pect omb593 mutants alone, pect omb593 mutants expressing SIP-IR using GMR-Gal4 relative to pect omb593 mutants expressing GMR-Gal4 alone, and eye-specific eas-IR with SREBP-IR relative to flies expressing eas-IR. Scale bar, 15 mm. Data are represented as mean ± SEM. Differences are significant at **p < 0.01 and ***p < 0.001 (one-way ANOVA; t test). n = 10 for each genotype. See also Figure S5 . We next examined the mechanism underlying this genetic interaction. SREBP is a transmembrane protein that is normally localized to the endoplasmic reticulum (ER) and is activated by proteolytic cleavage to release an N-terminal fragment that contains a helix-loop-helix DNA binding domain (Wang et al., 1994; Hua et al., 1995) . To test whether the genetic interaction between SREBP and pect mutants reflected increased transcriptional activity, we expressed a dominant-negative SREBP transgene in pect somatic mosaic animals. UAS-SREBP-NTDel contains a deletion in the highly acidic region of the N-terminal domain that is required for transcriptional activation (reviewed in Goldstein et al., 2002) . This dominant-negative protein retains the transcription factor in the endoplasmic reticulum. Eye-specific expression of this dominant-negative SREBP transgene in pect mutant R cells suppressed the loss of CSP staining but did not ameliorate the degeneration of the axon terminal ( Figures  5J-5L, 5P, and 5Q ). Finally, we knocked down S1P, the enzyme required for the first proteolytic cleavage in the SREBP activation cascade, in pect mutant R cells (Amarneh et al., 2009 ). This manipulation strongly suppressed the synaptic vesicle loss ( Figures 5M-5Q) . Thus, activation of SREBP by its canonical pathway is required for the loss of CSP staining seen in pect mutants.
Activated SREBP Is Upregulated in Pect Mutant R Cells
These genetic interactions predict that SREBP should be activated in pect mutants. We therefore determined whether pect mutant R cells contain elevated levels of the proteolytically cleaved, nuclear form of SREBP . In dissected retinas from control flies, we detected both the fulllength SREBP precursor (p-SREBP) as well as the shorter, nuclear form (n-SREBP; Figure 6A ). Importantly, both the full-length precursor and the activated, nuclear forms of SREBP were elevated in pect mutant retinas ( Figure 6A ). As these retinal dis-sections do not include the photoreceptor axon terminals, these changes in protein levels reflect changes in the cell body and nucleus. Finally, that both the full-length and activated forms of SREBP are elevated in these mutants is consistent with previous observations that vertebrate SREBP is positively auto-regulated (Sato et al., 1996) .
To examine whether increased levels of activated SREBP were associated with increased transcriptional activity, we took advantage of a Gal4-SREBP, UAS-GFP strain that acts as a transcriptional reporter of SREBP activation (Kunte et al., 2006) . In this reporter, the DNA binding domain of SREBP is replaced with Gal4-VP16 but retains all of the domains that target SREBP to the ER for processing. Thus, this Gal4-VP16-SREBP derivative is inactive until it has been subject to the normal proteolytic processing cascade associated with SREBP activation ( Figure 6B ). Higher levels of GFP expression thus reflect increased activated, nuclear SREBP. Control animals expressing this reporter displayed significantly lower levels of GFP fluorescence than pect mutant somatic mosaic animals ( Figure 6C ). This increase in GFP expression paralleled the progressive loss of synaptic marker expression seen in pect mutants, as reporter activity could not be detected on the day of eclosion, rose to modest levels by day 3, and was markedly higher on day 5 after eclosion (data not shown; Figures S6A-S6H ).
SREBP Activation Is Sufficient to Cause Synaptic Vesicle Loss
To test whether activation of SREBP alone was sufficient to induce synaptic vesicle loss in an otherwise wild-type animal, we took advantage of SREBP1-452, a truncated fragment of the N terminus that comprises the first 452 amino acids and contains the active transcription factor domain. This construct produces a constitutively active form of SREBP (Yang et al., 1994 (Yang et al., , 1995 . We used Rh1-Gal4 to restrict expression of this construct (C) Quantification of relative GFP labeling intensity. Day 3 control, day 3 pect omb593 mutants, day 5 control, and day 5 pect omb593 relative to day 3 control are shown. Data represented as mean ± SEM. Differences are significant at *p < 0.05 and **p < 0.01 (one-way ANOVA; t test). n = 10 for each genotype. See also Figure S6. to R1-R6 cells late in development and observed that expression of SREBP1-452 was sufficient to produce significant loss of synaptic vesicle labeling but had no effect on active zones, a phenotype qualitatively similar to the synaptic changes observed in pect mutants ( Figures 7A-7G) . Conversely, expression of full-length SREBP had no effect ( Figure S7A ). Consistent with this difference, western blot analysis revealed that increased expression of the activated form of SREBP was only observed using the UAS-SREBP1-452 transgene, not the full-length transgene ( Figure S7B) . Notably, when we overexpressed nuclear SREBP, we also observed increased levels of full-length SREBP, consistent with a positive auto-regulatory feedback loop, as we also observed in pect mutants ( Figure 6A ). To better compare the synaptic changes seen in pect mutants to those associated with expression of SREBP1-452, we compared expression of eight synaptic markers in pect mutant R cell terminals, and R cell terminals that were wild-type for (legend continued on next page) pect, but which expressed SREBP1-452. Of these eight markers, expression of five, namely CSP, syntaxin, DLG, synapsin, and Aa2/2, was reduced in pect mutants, and expression of three others, namely DPAK, dynamin, and Bruchpilot, was unaffected ( Figure S1A ). Expression of SREBP1-452 caused significant reductions in three of the five markers affected in pect mutants, namely CSP, syntaxin, and Aa2/2, leaving the remaining five markers unchanged ( Figure 7G) . A common feature of those markers with reduced expression is that all label synaptic vesicles. Thus, activation of SREBP causes a qualitatively similar but more specific pattern of synaptic marker loss than that seen in pect mutants.
R cell axon terminals in flies expressing SREBP1-452 exhibited many of the same synaptic phenotypes displayed in pect mutant terminals but lacked the degenerative changes in the axon terminal and cell body. As in pect mutants, expression of SREBP1-452 caused a reduction in the packing density of synaptic vesicles and resulted in the increased presence of structures with the morphological character of endoplasmic reticulum ( Figures 7H-7K and S7C ). SREBP1-452 mutant cartridges at 2 or 3 days after eclosion exhibited a range of R1-R6 terminal phenotypes, some with enlarged profiles that lacked most capitate projections and had extensive structures with the morphological character of smooth endoplasmic reticulum and occasional profiles of dense core vesicles neighboring other, more normal terminals ( Figures 7H-7K ). The density of T-bar ribbon profiles around the perimeter of the R-cell terminal was also lower than in control terminals ( Figure S7D ). Finally, the structure of R cell bodies was also slightly perturbed in R cells expressing SREBP1-452 compared with those in control ommatidia ( Figures S7E and S7F) . Thus, activation of SREBP in R1-R6 cells is sufficient to cause synaptic vesicle loss.
We next examined whether activation of SREBP affects either the transcription of synaptic genes, the levels of synaptic proteins, or both. To do this, we performed reverse transcription qPCR on cDNA isolated from dissected retinas comparing flies expressing SREBP1-452 to those expressing UAS-mCD8-GFP and examined two of the most prominent synaptic proteins, CSP and syntaxin. These studies revealed that expression of SREBP1-452 changed the mRNA expression levels for each of these two genes less than 2-fold (1.61-fold for CSP; 0.78-fold for syntaxin; comparing SREBP1-452 to mCD8-GFP). We also performed western blot analysis on dissected retinas of the same genotypes and examined CSP and syntaxin protein levels. We observed that expression of SREBP1-452 caused a 11.9-fold decrease in CSP protein levels and a 2.2-fold decrease in syntaxin protein levels ( Figure S7G ). Thus, for both of these genes, the changes in transcription were insufficient to account for the observed changes in protein levels arguing that SREBP activation likely has indirect effects on these genes.
RNA Profiling Identifies Nuclear SREBP-Induced Transcriptional Changes
To identify SREBP target genes that might mediate this regulatory effect, we performed RNA sequencing (RNA-seq) analysis of dissected adult retinal tissue 5 days after eclosion to identify potential causal targets. We compared gene expression profiles in which Rh1-Gal4 was used to express mCD8-GFP versus SREBP1-452. We detected the transcripts of 8,924 genes in the two control replicates as well as 8,885 genes in the two SREBP1-452 replicates ( Table S2 ). Both of these datasets included 20/22 (91%) of the genes previously known or implicated in retinal degeneration or phototransduction, as well as 37/93 (40%) of the genes identified as differentially expressed between wild-type heads and heads derived from eyeless flies (Xu et al., 2004) . Thus, this dataset represents a significant fraction of the adult retinal transcriptome. In our dataset, only 219 genes (2.46% of the SREBP 1-452 transcriptome; p < 0.0011) changed expression when SREBP was activated ( Figure 8A) . 128 of these genes increased expression between 2-and 24fold; 91 of these genes decreased expression between 2-and 62-fold ( Figure 8B ). To validate these changes, we selected 10 genes for qPCR, eight of which had large decreases in expression according to our RNA-seq analysis and two of which displayed no significant difference. These qPCR results were entirely consistent with our RNA-seq studies ( Figure S8A) .
Expression of 27 genes was strongly affected by SREBP activation, causing changes in expression of approximately 8-fold or greater (Table S2 ). Of these, 14 genes were significantly upregulated, all of which were only weakly expressed in wild-type photoreceptors and remained expressed at low levels when SREBP was activated (Table S2 ). Conversely, the 13 genes that were downregulated by activation of SREBP were expressed at a variety of levels in wild-type R cells. As we will discuss further below, this subset of genes included two members of the tetraspanin family, Tsp42Eo and Tsp42En, located at adjacent chromosomal loci. More broadly, SREBP activation affected the expression of 5 genes involved in lipid biosynthesis, 20 genes that had previously been described as playing roles in phototransduction or retinal structure, and 17 additional genes with Data represented as mean ± SEM. Differences are significant at ***p < 0.001 (one-way ANOVA). Scale bar, 15 mm. n = 9 for each genotype. See also Figure S8 and Table S2 . synaptic functions ( Figure 8C) . Strikingly, 19 of 20 phototransduction genes as well as 14 of 17 synaptic genes were downregulated by SREBP activation (Figure 8C ). Taken together, these data demonstrate that activation of SREBP regulates a handful of lipid biosynthetic genes and reduces expression of many genes involved in phototransduction, synaptic transmission, and R cell structure.
Tetraspanins Are Functionally Critical Targets of SREBP Regulation
This RNA-seq dataset provided a list of candidate SREBP target genes, a subset of which could be functionally critical. We noted that four members of the tetraspanin family, Tsp42Eo, Tsp42En, Tsp42Ej, and Tsp39D, were downregulated by SREBP1-452. Tetraspanins are transmembrane proteins that regulate synaptic development in flies and vertebrate photoreceptor morphology (Kopczynski et al., 1996; Travis et al., 1991; Bascom et al., 1992) . We therefore hypothesized that this gene family might represent functionally important SREBP effectors. As genetic tools existed to allow photoreceptor-specific overexpression of Tsp39D and Tsp42Eo, we compared the effects of co-expressing these two genes with SREBP1-452 to the effects of co-activating four other genes that were also downregulated by SREBP activation, namely pale, no receptor potential A, Ggamma30A, and Galpha49B. Remarkably, co-expression of either Tsp39D or Tsp42Eo significantly suppressed the effects of SREBP 1-452 on CSP expression ( Figures 8D-8G and 8J ). However, although three of the four control genes had no effect, we also observed phenotypic suppression using a ple transgene. To determine whether these genetic interactions reflected the activities of bona fide downstream effectors of SREBP versus artefactual effects on expression of the SREBP1-452 transgene (caused by the presence of additional Gal4 binding sites associated with the interacting transgene), we performed western blots on dissected retinas and stained for SREBP. These studies revealed that, although Tsp39D expression had no effect on the level of SREBP1-452, expression of Ple reduced SREBP1-452 levels ( Figure S8B ). Thus, Tsp39D, but not Ple, acts as a downstream effector of SREBP.
If downregulation of tetraspanins causes synaptic vesicle loss in response to SREBP activation, upregulation of tetraspanins should suppress the synaptic phenotypes associated with mutations in pect. However, the tetraspanin loci we identified, Tsp39D, and the Tsp42E complex lie extremely close to the centromere, meaning that they cannot be used in mosaic clones with pect-null alleles. As an alternate approach, we took advantage of the easily shocked (EAS) knockdown manipulation that causes phenotypes similar to those seen in pect mutants (Figure S5) . Remarkably, overexpression of Tsp39D in the Eas knockdown background suppressed the loss of CSP staining (Figures 8H-8J) . Thus, at least some tetraspanins are functional downstream effectors of SREBP.
DISCUSSION
Summary
These studies demonstrate that disrupting the biosynthesis of specific membrane phospholipids causes adult-onset degener-ation of R cells and loss of synaptic vesicles. These two phenotypes arise via distinct molecular mechanisms that can be doubly dissociated using genetic and physiological manipulations ( Figures S9A-S9E) . Degeneration of the axon terminal is an activity-dependent process that requires calcium-mediated vesicle fusion. Conversely, loss of synaptic vesicles is driven by activation of the transcription factor SREBP. Thus, in these cells, SREBP is activated by alterations in the levels of specific phospholipids. Here, SREBP affects the expression of a specific subset of genes that are largely not directly involved in lipid regulation, thus defining a previously unknown SREBP function. Rather, SREBP activation leads to reduced expression of four tetraspanins. Restoring expression of either of two of these tetraspanins suppresses the effects of SREBP activation, demonstrating that tetraspanins are functional effectors of SREBP in photoreceptors. Thus, a specialized feedback loop from the synaptic terminal to the nucleus links the levels of specific phospholipids to photoreceptor function and synaptic vesicle number. We propose that this feedback loop matches the vesicular demand for phospholipids to their production. As SREBP is evolutionarily conserved, and recent studies have linked SREBP to neuronal damage in several contexts, we speculate that this feedback loop plays a central role in maintaining synaptic vesicle pools in the healthy aging brain.
The Relative Levels of Specific Phospholipids Are Critical to Neuronal Structure and Function
In Drosophila, mutations that disrupt phospholipid biosynthesis cause broad defects in brain function, including increased seizure activity and photoreceptor degeneration (Pavlidis et al., 1994; Midorikawa et al., 2010) . However, these and other studies examining phospholipid composition in flies have either not quantified phospholipid levels or have not differentiated different phospholipid species (Pavlidis et al., 1994; Midorikawa et al., 2010; Lim et al., 2011) . Our studies using a high-resolution lipidomic approach demonstrate that biosynthesis of specific PE and PC species is required for maintaining synaptic vesicle pools and the axon terminal in adult photoreceptors. Moreover, the biosynthetic enzyme Pect is found at the axon terminal. We speculate that the production of specific phospholipids can occur locally, coupling precise levels of phospholipids to the cellular processes that require them in the axonal compartment. Finally, recent work has demonstrated that derivatives of very long chain (VLC) PC species are neuroprotective in vertebrate photoreceptors and neurons Bhattacharjee et al., 2017) . Although we detected only one VLC PC precursor, PC c44:12, representing 0.01% of the total PC species in the fly retina (Table S1) , future studies will determine the extent to which derivatives of this or other PC or PE species play roles in maintaining adult photoreceptor axons and synapses in Drosophila.
Our work suggests the following model ( Figure S9B ). Our ultrastructural analysis of pect mutants reveals phenotypes in the axon terminal that are strongly reminiscent of those in endocytic mutants Verstreken et al., 2003; Dickman et al., 2005) . Consistent with this, blocking exocytosis in pect mutants by either reducing light exposure or by genetic means suppresses axon terminal degeneration. We infer then that the inability to retrieve synaptic vesicles from the plasma membrane is sufficient to cause neuronal degeneration and that the availability of specific phospholipids can be rate limiting for endocytosis. These results are consistent with previous studies in C. elegans that demonstrated that a phospholipid desaturase causes defects in endocytosis through effects on synaptojanin, a critical component in endocytosis (Marza et al., 2008) . At the same time, altering phospholipid production may also impair vesicle biogenesis, in which case blocking synaptic transmission could suppress neuronal degeneration by removing the demand for vesicle biogenesis via an as-yet-unknown mechanism.
A Previously Undescribed Function for SREBP in Adult R Cells SREBP is a central regulator of genes involved in lipid biosynthesis in many cell types (Rawson, 2003) . Our data support the notion that SREBP plays an additional role in Drosophila photoreceptors. As the levels of only a few phospholipids are altered in pect mutants, SREBP activation appears linked to the detection of changes in levels in these PE and PC species. Moreover, although activation of SREBP does upregulate a small number of genes involved in lipid biosynthesis, it also downregulates many genes involved in phototransduction and synaptic function. Among these, our genetic interaction studies demonstrate that tetraspanins are functionally critical SREBP effectors. Tetraspanins are transmembrane proteins that have been linked to synapse development (Kopczynski et al., 1996) , lysosomal function in R cells (Xu et al., 2004) , and to outer segment structure and function in the vertebrate retina (Travis et al., 1991; Bascom et al., 1992) . Moreover, recent work has demonstrated that they can serve as cholesterol-binding proteins, further implicating this family in the regulation of membrane function (Zimmerman et al., 2016) . Although unraveling the specific molecular mechanisms that link tetraspanin function to synaptic vesicle pools remains a challenge for future studies, our model for this role of SREBP represents an extension of SREBP's long-standing role in regulating lipid biosynthesis. In particular, a central role for phospholipids that is unique to neurons is as a critical component of synaptic vesicles. We hypothesize that, when SREBP is activated and tetraspanin expression is reduced, either the biogenesis of synaptic vesicles is downregulated or their turnover and degradation is increased, shrinking the synaptic vesicle pool in an activity-independent manner. As a result, the cellular demand for the specific phospholipids found in synaptic vesicles is reduced. More broadly, these studies suggest that SREBP might complement its long-standing role in lipid biosynthesis with an additional role in controlling phospholipid utilization. Finally, by combining the high-resolution lipidomic approach we have developed to work with small populations of labeled cells with the powerful genetic tools available in this system, future work may shed further light on the regulation of SREBP activity and phospholipid levels.
A Role for SREBP in Neurological Disease SREBP has been linked to both neurodegenerative disease and stroke (Taghibiglou et al., 2009; Do et al., 2011; Barbero-Camps et al., 2013) . Recent studies in flies have demonstrated that reactive oxygen species can activate SREBP to cause lipid droplet formation in glia (Liu et al., 2015) . However, the molecular mechanisms by which SREBP might act in these contexts are unknown. In addition, mutations in a human tetraspanins have been linked to intellectual disability (Bassani et al., 2012; Verpelli et al., 2013) . Our demonstration that SREBP acts through tetraspanins to regulate synaptic vesicle pools and negatively regulates other genes required for synaptic function suggests a unifying mechanism for these seemingly disparate observations. Taken together, these studies argue that SREBP plays an evolutionarily conserved role in regulating neuronal and synaptic function, suggesting a link between the neuronal phospholipid repertoire and synapse maintenance in the adult brain.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
Semithin Sections
Adult eyes were prepared for dissection, fixation, and embedding in epoxy (Gaengel and Mlodzik, 2008) . Semithin sections were mounted on slides using DPX mounting medium. Images were acquired on a Zeiss Axio Imager.Z1 microscope using a 100X objective lens with an AxioCam HR microscope camera.
Electron Microscopy
Organelle counts from mutant and control R1-R6 photoreceptor terminals were made from the means of the means for 3 flies, with approximately 15 profiles per fly. We counted the numbers of profiles of synaptic organelles: synaptic vesicles, T-bar ribbons at synapses, and capitate projections, sites of invagination into the photoreceptor terminal by surrounding epithelial glial cells (Stark and Carlson, 1986 ). These were counted as one of three related forms of EM profile (Pyza and Meinertzhagen, 1998) : shallow (with a head invaginating not more than half its diameter); single (penetrating, with a single head profile); or multiple-headed (penetrating, with more than one head). To express these profile counts with respect to the size of the R1-R6 terminal profile, we normalized the raw counts to the length of the R1-R6 profile perimeter and cross-sectional area, measured using software (ImageJ, NIH). We tested organelle counts for statistical significances first by an unweighted means ANOVA, followed by a Tukey HSD test, using software (Systat 5.2.1). We also marked the x,y coordinates for the centers of synaptic vesicle profiles, to determine spatial dispersion, using previously reported methods (Dickman et al., 2005) and spatial statistics (Clark and Evans, 1954) .
Immunohistochemistry
Adult brains were dissected in 2% PLP under previously described conditions . The following antibodies were used: mouse anti-Chaoptin mAb24B10 (1:20, Developmental Hybridoma Bank), mouse anti-CSP (1:10), mouse anti-Syntaxin (1:10), mouse anti-Bruchpilot (1:10 
Confocal Imaging
Images were acquired on a Leica TCS SP2 AOBS confocal microscope, using a 40x NA 1.25 lens. Images were rendered using Imaris (Bitplane), and figures were prepared using Photoshop and Illustrator (Adobe).
Quantification of Immunolabeling
Anti-Chaoptin and anti-CSP were used as reference immunolabels in order to delineate the area of interest for each lamina section. First, reference staining images were filtered (using a 2D averaging filter with fixed window size). Subsequently, images were thresholded (by the mean pixel intensity in the filtered image), eroded (using a fixed size square structuring element), and holes, if present, were filled. Pixel intensities from raw images were analyzed within these defined areas of interest using a fixed threshold value, and the total fraction of pixels above the fixed threshold value was determined. Quantification analysis was performed using MATLAB. For the degeneration phenotype, cartridges were counted manually, and the number of complete cartridges containing 6 R cell terminals was divided by the total number of cartridges scored. Statistical analysis was performed by one-way ANOVA using GraphPad (Prism).
Western Blot and Immunoblotting
Aliquots were boiled for 5 min and subjected to SDS-PAGE on an 8% polyacrylamide gel, before transfer to nitrocellulose. Blots were then incubated in 7% milk in TBS-Tween. After 1 h, blots were washed in TBS-Tween, then incubated overnight in mouse anti-dSREBP-N terminus (3B2, a generous gift from Dr. Robert Rawson). Subsequently, blots were incubated in goat anti-mouse IgG-HRP (Santa Cruz Biotechnology) in 7% milk for 1 h. Blots were incubated with Thermo Scientific SuperSignal West Dura Chemiluminescent substrate and then exposed to film. After film was processed, blots were stripped and re-probed overnight with rat anti-tubulin (Abcam 6161) overnight, incubated in goat anti-rat IgG-HRP (Santa Cruz Biotechnology), and processed as described above. Blots were quantified using ImageJ (NIH).
Western Blot Quantification
Western blot quantification was performed using ImageJ analysis. Lanes were identified using ImageJ with calculation of area under the curve. For each band, the relative density, of each band to the control condition, was calculated. Subsequently, the adjusted density, the relative density of each sample divided by the relative density of the loading control, was then determined.
RNA profiling
RNA was isolated from eyes as specified above and measured using a Bioanalyzer RNA 6000 Nano kit (Agilent Technologies), NanoDrop 2000 (Thermo Scientific), and Qubit Fluorometer (Invitrogen). Fragmented double-stranded cDNA were prepared using TruSeq RNA Sample Preparation Kit (Illumina) and used for sequencing library preparation automatically with an Illumina TruSeq adaptor on the SPRIWorks System I (Beckman-Coulter) by using cartridges and method cards specific to the Illumina sequencing system, followed by specific PCR enrichment. The sequencing reactions were performed using the Illumina Genome Analyzer IIX (SR36x1) sequencing platform according to manufacturer's instructions, with two biologic replicates per genotype. High-throughput sequencing was performed using the Stanford Functional Genomics Facility.
RNA profiling analysis
Initially, all reads were analyzed for quality using Galaxy (Blankenberg et al., 2010a (Blankenberg et al., , 2010b . Reads were subsequently mapped to the Drosophila melanogaster reference genome using TopHat (Trapnell et al., 2009 ). Mapped reads were then analyzed using Cufflinks to generate a FPKM score (Trapnell et al., 2010 (Trapnell et al., , 2012 . CuffDiff was used to compare Cufflink files from all conditions. This enabled the generation of both p and q values after significance testing between groups, taking biologic replicates into account.
Phospholipid Extraction
Phosholipids from disected retinas were extracted by a Folch extraction. Approximately 10 dissected retinas were used for each biological replicate. Chloroform:methanol (2:1, v/v) was added to sonication for 15 s in ice. This homogenate was ground with a dounce homogenizer on ice and CaCl 2 (0.025%) was added. After 10 min shaking, this mixture was centrifuged and bottom layer removed. The upper layer was washed with chloroform:methanol and centrifuged. The bottom layers were combined and dried under N 2. Phospholipid extracts were resuspended in 75% acetonitrile 25% water/methanol solution prior to LC/triple quad MS analysis.
Mass Spectrometry
Phospholipid extracts were analyzed using LC/triple quad MS . Phospholipid separation was subjected to normal phase chromatography using an Agilent 1260 Infinity LC system followed by MS analysis using an Agilent 6430 Triple-Quad LC/MS system (Santa Clara, CA) to obtain the relative abundance of PC and PE phospholipids. The MS was operated in multiple reaction monitoring mode (MRM) and positive ion mode.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed in Graphpad Prism 7. For both one-and two-way ANOVA analyses, Bonferonni corrected twotailed tests were performed. Error bars represent standard error of the mean.
DATA AND SOFTWARE AVAILABILITY
Please see Table S2 .
The RNA-sequencing data have been deposited in the Sequence Read Archive (SRA) with BioProject ID PRJNA512933 and the following URL links: https://www.ncbi.nlm.nih.gov/bioproject/512933, https://www.ncbi.nlm.nih.gov/biosample/10690876, https:// www.ncbi.nlm.nih.gov/biosample/10690877, https://www.ncbi.nlm.nih.gov/biosample/10690878, and https://www.ncbi.nlm.nih. gov/biosample/10690879.
